Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P14
Within normal range
vs 2Y Ago
-6.9x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-159.58%
2024-81.57%
202323.20%
2022-44.93%
2021-46.61%
2020-78.71%
201949.70%
2018-724.89%
2017112.93%
2016-46.28%